Cytospire hauls in $83M for a new type of T cell engager
The British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies.
ORIGINAL SOURCE →via Biopharma Dive
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · GB
- [CONFLICT] Şampiyonluk yolunda inanılmaz hata! Manchester City, Everton'a takıldı...
- [CONFLICT] Foden reaches agreement over new Man City deal
- [CONFLICT] EQT Raises Bid for Product Testing Firm Intertek to £8.9 Billion
- [AVIATION] British Airways Boeing 787 Dreamliner Grounded After it Was Impaled By Engineering Steps As Passengers Watched On From Crowded Bus
- [CONFLICT] Adı Galatasaray ile anılmıştı: İtalyan basınından flaş Bernardo Silva iddiası!
- [CONFLICT] Police Help Families of Geese Cross London Street